益气活血逐瘀方治疗气虚血瘀型冠心病稳定型心绞痛临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.4

基金项目:


Clinical Study on Yiqi Huoxue Zhuyu Prescription for Stable Angina Pectoris of Coronary Heart Disease of Qi Deficiency and Blood Stasis Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察益气活血逐瘀方治疗气虚血瘀型冠心病稳定型心绞痛的疗效及对凝血指标、炎症因子的影响。方法:选择88 例气虚血瘀型冠心病稳定型心绞痛患者,按随机数字表法分为治疗组45 例与对照组43 例。对照组采取西医常规治疗,治疗组采取益气活血逐瘀方联合西医常规治疗,连续治疗3 个月。对比2 组临床疗效、中医证候积分、凝血功能及血清炎症因子。结果:治疗组中医证候疗效93.33%,优于对照组76.74%(P<0.05)。与同组治疗前比较,2 组治疗后中医证候积分、心绞痛症状积分、纤维蛋白原(FIB) 及血清白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α) 水平均降低(P<0.05),血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT) 均升高(P<0.05);与对照组治疗后比较,治疗组治疗后中医证候积分、心绞痛症状积分、FIB 水平及血清IL-6、TNF-α 水平均较低(P<0.05),PT、APTT 均较高(P<0.05)。结论:益气活血逐瘀方用于治疗气虚血瘀型冠心病稳定型心绞痛疗效确切,可缓解临床症状,改善凝血功能指标,有效抑制炎症反应。

    Abstract:

    Abstract: Objective: To observe the curative effect of Yiqi Huoxue Zhuyu prescription on stable angina pectoris of coronary heart disease of qi deficiency and blood stasis type and its effects on coagulation indexes and inflammatory factors. Methods:A total of 88 cases of patients with stable angina pectoris of coronary heart disease of qi deficiency and blood stasis type were selected and divided into the treatment group and the control group according to the random number table method, 45 and 43 cases in each group respectively. The control group was treated with routine western medicine treatment, and the treatment group was additionally given Yiqi Huoxue Zhuyu prescription based on the treatment of the control group. Both groups were treated for three months. Clinical effects,Chinese medicine syndrome scores,coagulation function and serum inflammatory factors were compared between the two groups. Results:The curative effect of Chinese medicine syndrome was 93.33% in the treatment group, better than that of 76.74% in the control group(P<0.05). After treatment,Chinese medicine syndrome scores,scores of angina pectoris symptoms,as well as levels of fibrinogen(FIB), serum interleukin-6(IL-6),tumor necrosis factor-α(TNF-α) in the two groups were decreased when compared with those before treatment(P<0.05);plasma prothrombin time(PT) and activated partial thromboplastin time(APTT) were increased(P< 0.05). After treatment,Chinese medicine syndrome scores,scores of angina pectoris symptoms,as well as levels of FIB, serum IL-6 and TNF- α in the treatment group were lower than those in the control group,and PT and APTT were higher(P< 0.05). Conclusion: The therapy of Yiqi Huoxue Zhuyu prescription has a defined curative effect in the treatment of stable angina pectoris of coronary heart disease of qi deficiency and blood stasis type, which can relieve clinical symptoms, improve indexes of coagulation function,and effectively inhibit inflammatory responses.

    参考文献
    相似文献
    引证文献
引用本文

吴一凡,王舒舒,叶小嬉嬉.益气活血逐瘀方治疗气虚血瘀型冠心病稳定型心绞痛临床研究[J].新中医,2021,53(21):72-75

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-11-12
  • 出版日期:
文章二维码